GGrantIndex
Sort

326,823 grants matching clinical trial

ANTI-HIV RNA TRANSDUCTION INTO BLOOD STEM CELLS IN AIDS

$1,754,493
City Of Hope/Beckman Research Institute · P01 · FY2002 · AI

QUALITY ASSURANCE REVIEW CENTER (QARC)

$1,754,486
Thomas J Fitzgerald · Univ Of Massachusetts Med Sch Worcester · U10 · FY2006 · CA

Clinical Evaluation of a Resorbable Vena Cava Filter

$1,754,160
Mitchell Eggers · Adient Medical, Inc. · R44 · FY2017 · HL

Center for Cancer Systems Therapeutics (CaST)

$1,754,138
Andrea Califano · Columbia University Health Sciences · U54 · FY2023 · CA

Molecular-Based Therapy for Oral Cancer Prevention

$1,754,100
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2006 · CA

TREATMENT OF LEAD EXPOSED CHILDREN FOLLOW UP

$1,753,980
University Of Cincinnati · U01 · FY2000 · ES

Pragmatic Trial of the Effectiveness and Cost-Effectiveness of Dementia Care

$1,753,930
David B. Reuben · University Of California Los Angeles · R01 · FY2018 · AG

ADULT AIDS CLINICAL TRIALS UNIT

$1,753,886
Michael Marcel Lederman · Case Western Reserve University · U01 · FY2006 · AI

Quantitative Imaging of Water Transport and Relaxation Processes in the Brain and in Other Soft Tissues

$1,753,880
Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD

STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS

$1,753,867
Dana-Farber Cancer Institute · P50 · FY2002 · HL

Mechanisms of Risk and Resilience in ASD: Ontogeny, Phylogeny and Gene Disruption

$1,753,839
Ami Klin · Emory University · P50 · FY2014 · MH

Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN)

$1,753,747
Adeline Lucie Vanderver · Children'S Hosp Of Philadelphia · U54 · FY2025 · NS

Transdisciplinary Versus Usual Care for Type 1 Diabetes in Adolescence

$1,753,737
Melissa A. Alderfer · Nemours Children'S Clinic · DP3 · FY2017 · DK

AZD9688: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency a Genetically Linked Orphan Disease

$1,753,722
Mark T Dransfield · University Of Alabama At Birmingham · UH3 · FY2018 · TR

New therapeutic vulnerabilities in breast cancer

$1,753,720
Kornelia Polyak · Dana-Farber Cancer Inst · P01 · FY2021 · CA

Reducing Cervical Cancer in Appalachia

$1,753,695
Electra D. Paskett · Ohio State University · P50 · FY2012 · CA

PHASE I CLINICAL TRIAL UNIT FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES

$1,753,448
John McLeod Griffiss · Icon Government And Public Health Solutions, Inc. · N01 · FY2011 · AI

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$1,753,447
David S Guzick · University Of Rochester · UL1 · FY2007 · RR

NK cells, their receptors and cancer therapy

$1,753,270
Jeffrey S Miller · University Of Minnesota · P01 · FY2022 · CA

Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain

$1,753,199
Denise Wilkes · University Of Texas Med Br Galveston · RM1 · FY2024 · NS

Hereditary Muscle Disease Unit

$1,753,186
Ami Mankodi · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS

DNA Sequencing and FACS Core Facilities

$1,753,141
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA

TAS::75 0843::TAS HORMONE THERAPY AND COGNITIVE AGING IN OLDER AND YOUNGER POSTM

$1,753,125
Sally Shumaker · Wake Forest University Health Sciences · N01 · FY2014 · AG

Mayo Clinic Ovarian Cancer SPORE

$1,752,990
Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2023 · CA

Modulation of Therapeutic Response

$1,752,978
James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA